Vaccine-related adverse events following ChAdOx1-nCoV-19 vaccine in actively treated patients with solid malignancy, as compared to age-matched healthy controls.

被引：0
|
作者：
Pakvisal, Nussara
Sainamthip, Panot
Teeyapun, Nattaya
Luangdilok, Sutima
Wanchaijiraboon, Passakorn
Wanlapakorn, Nasamon
Susiriwatananont, Thiti
Zungsontiporn, Nicha
Sriuranpong, Virote
Poovorawan, Yong
Yorsaeng, Ritthideach
Namkanisorn, Teerayuth
Tanasanvimon, Suebpong
机构：
[1] Chulalongkorn Univ, Div Med Oncol, Dept Med, Bangkok, Thailand
[2] Chulalongkorn Mem Hosp, Bangkok, Thailand
[3] Chulalongkorn Univ, Dept Pharmacol, Fac Med, Bangkok, Thailand
[4] King Chulalongkorn Mem Hosp, Bangkok, Thailand
[5] Chulalongkorn Univ, Fac Med, Devis Med Oncol, Dept Med, Bangkok, Thailand
[6] Chulalongkorn Univ, Dept Biochem, Fac Med, Bangkok, Thailand
[7] Phrapokklao Hosp, Phrapokklao Canc Ctr Excellence, Chanthaburi, Thailand
[8] Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok, Thailand
[9] Chulalongkorn Univ, Div Med Oncol, Dept Med, Fac Med, Bangkok, Thailand
[10] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Div Med Oncol, Fac Med, Bangkok, Thailand
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13517
引用
收藏
页数：1
相关论文
共 17 条
  • [11] Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal
    Rayamajhi, Sushil
    Rafi, Md. Abdur
    Tripathi, Nishant
    Dongol, Anjana Singh
    Pandey, Minalma
    Rayamajhi, Shreejana
    Bhandari, Subhechchha
    Shrestha, Pranay
    Hasan, M. Tasdik
    Hossain, Md. Golam
    PLOS ONE, 2022, 17 (08):
  • [12] Active Symptom-Based Surveillance of Adverse Events Following Immunization Among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala
    Jose, Maria
    Rajmohan, Priyanka
    Thomas, Joe
    Krishna, Swathi
    Antony, Beena
    Gopinathan, Unnikrishnan U.
    Iyyapan, Elsy M.
    Porinchu, Raphael M.
    Jose, Ponnu
    Raphael, Lucy
    Kuttichira, Praveenlal
    CURRENT DRUG SAFETY, 2022, 17 (04) : 327 - 334
  • [13] Comparing ChAdOx1 nCoV-19 Coronavirus Vaccine (Recombinant) (Covishield) and BBV152; Bharat Biotech COVID-19 Vaccine (Covaxin) for COVID-19: Reports of Adverse Events Following Vaccination among the Indian Population
    Kaur, Sukhpal
    Rohilla, Latika
    Kayina, Choro Athiphro
    Kaur, Jasvir
    Kaur, Gurpreet
    Walia, Anjani
    Kumar, Pramod
    Singh, Ajay
    Saini, Sushma
    Soni, Shiv Lal
    Malhotra, Pankaj
    INDIAN JOURNAL OF PUBLIC HEALTH, 2025, 69 (01) : 27 - 32
  • [14] Immune mediated events timely associated with COVID-19 vaccine. A comment on article by Badier, et al.: "IgA vasculitis in adult patients following vaccination by ChadOx1 nCoV-19"
    Hocevar, Alojzija
    Tomsid, Matija
    AUTOIMMUNITY REVIEWS, 2022, 21 (02)
  • [15] Incidence, Pattern and Severity of Adverse Events Following Immunization (AEFIs) Associated With Chadox1 nCOV-19 Corona Virus Vaccine (Recombinant) Among the Healthcare Workers of a Tertiary Care Institute of Eastern Uttar Pradesh, India
    Kamble, Bhushan
    Abu Bashar, Md
    Mishra, Chandra Pati
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [16] Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222)
    Roman, Gustavo C.
    Gracia, Fernando
    Torres, Antonio
    Palacios, Alexis
    Gracia, Karla
    Harris, Diogenes
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [17] Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac
    Wanchaijiraboon, Passakorn
    Sainamthip, Panot
    Teeyapun, Nattaya
    Luangdilok, Sutima
    Poovorawan, Yong
    Wanlapakorn, Nasamon
    Tanasanvimon, Suebpong
    Sriuranpong, Virote
    Susiriwatananont, Thiti
    Zungsontiporn, Nicha
    Pakvisal, Nussara
    VACCINES, 2023, 11 (02)
12